Cargando…
Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma
BACKGROUND: BCL2L13 belongs to the BCL2 super family, with its protein product exhibits capacity of apoptosis-mediating in diversified cell lines. Previous studies have shown that BCL2L13 has functional consequence in several tumor types, including ALL and GBM, however, its function in kidney cancer...
Autores principales: | Meng, Fei, Zhang, Luojin, Zhang, Mingjun, Ye, Kaiqin, Guo, Wei, Liu, Yu, Yang, Wulin, Zhai, Zhimin, Wang, Hongzhi, Xiao, Jun, Dai, Haiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247248/ https://www.ncbi.nlm.nih.gov/pubmed/34193180 http://dx.doi.org/10.1186/s12935-021-02039-y |
Ejemplares similares
-
Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
por: Chen, Lujun, et al.
Publicado: (2019) -
CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin/ERK signaling pathway
por: Zhang, Xiaowei, et al.
Publicado: (2018) -
BC094916 suppressed SP 2/0 xenograft tumor by down-regulating Creb1 and Bcl2 transcription
por: Xu, Ruonan, et al.
Publicado: (2018) -
Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma
por: Wang, Song, et al.
Publicado: (2021) -
Up regulation of Bax and down regulation of Bcl2 during 3-NC mediated apoptosis in human cancer cells
por: Naseri, Mohammad Hassan, et al.
Publicado: (2015)